MicroRNAs in bladder cancer: expression profiles, biological functions, regulation, and clinical implications

Zhaoqi Shi1, Qingxia Wei2, Mingxin Zhang3

  • 1Department of General Surgery, 1st Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, 710061, Shaan'xi Province, China.

Insights

MicroRNAs (miRNAs) play key roles in bladder cancer (UBC) progression. Understanding their deregulation offers insights into UBC mechanisms and potential diagnostic markers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Bladder cancer (UBC) is a prevalent malignancy with high recurrence rates.
  • The molecular underpinnings of UBC remain incompletely elucidated.
  • MicroRNAs (miRNAs) are small noncoding RNAs crucial in cellular processes.

Purpose of the Study:

  • To review miRNA expression profiles, biological functions, and regulation in UBC.
  • To explore the clinical implications of miRNAs in UBC.
  • To highlight the potential of miRNAs as diagnostic and prognostic biomarkers.

Main Methods:

  • Literature review of studies on miRNA expression and function in UBC.
  • Analysis of miRNA deregulation mechanisms (epigenetic changes, biogenesis defects).
  • Examination of miRNA involvement in UBC hallmarks (proliferation, apoptosis, metastasis, drug resistance).

Main Results:

  • miRNA expression is frequently altered in UBC.
  • miRNA deregulation impacts critical UBC progression pathways.
  • Specific miRNAs, including those in urine, correlate with tumor characteristics and patient survival.

Conclusions:

  • miRNAs are significantly implicated in the development and progression of UBC.
  • miRNAs hold promise as novel diagnostic and prognostic tools for bladder cancer.
  • Further research into miRNA roles will advance understanding of UBC molecular mechanisms.